The protective effect of rosuvastatin on ischemic brain injury and its mechanism

Abstract

To study the protective effect of rosuvastatin on ischemic brain injury and its mechanism, focal cerebral ischemia/reperfusion was induced by occlusion of the middle cerebral artery (MCA) using the intra-luminal filament technique. The cerebral blood flow was monitored with laser-Doppler flowmetry (LDF). The slices of brain tissue were stained with cresyl-violet. The cerebral volume of infarction and edema were quantified with ImageJ software. The expressions of endothelial NO synthase (eNOS) and activated caspase-3 were detected with Western blot. The inducible NO synthase (iNOS) positive cells were immunohistochemically observed. The results demonstrated that rosuvastatin (20 mg/kg) could remarkably decrease infarct volume and cerebral edema after MCAO 90 min/reperfusion 24 h. Western blots showed that the expression of eNOS in cerebral cortex before and after ischemia was (100±43.3) %, (1668.9±112.2) % respectively (P<0.001), rosuvastatin significantly up-regulated the expression of eNOS in non-ischemic cortex (P<0.001), whereas in ischemic cortex of rosuvastatin group the expression of eNOS was (1678.8±121.3) %. There was no expression of activated caspase-3 in non-ischemic cortex, nonetheless the expression of activated caspase-3 increased after ischemia, and rosuvastatin significantly diminished it (P<0.01). Immunohistochemistry revealed no iNOS-positive cells in non-ischemic brain area, while in ischemic brain area the number of iNOS positive cells went up, and rosuvastatin could significantly reduced them. Consequently, the mechanisms of rosuvastatin’s neural protection on ischemic brain injury are to enhance expression of eNOS, to inhibit expression of iNOS and activated caspase-3.

Keywords

rosuvastatin / cerebral ischemia/reperfusion / NOS / caspase-3

References

[1] TeramotoT., WatkinsC.. Review of efficacy of rosuvastatin 5 mg. Int J Clin Pract, 2005, 59(1): 92-101

[2] MeyboomR. H., EdwardsI. R.. Rosuvastatin and the statin wars — the way to peace. Lancet, 2004, 364(9450): 1997-1999

[3] GrosserN., ErdmannK., HemmerleA., et al.. Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1. Biochem Biophys Res Commun, 2004, 325(3): 871-876

[4] DunX. L., LiF., FangZ.. Preventive effects of simvastatin on glucocorticoid induced early necrosis of femoral head. Acta Med Univ Sci Technol Huazhong, 2006, 35(3): 346-349

[5] WangY., KilicE., Kilic, et al.. Brain-selective VEGF overexpression induces post-ischemic neuroprotection, but also facilitates hemodynamic steal phenomena. Brain, 2005, 128(Pt1): 52-63

[6] MontanerJ.. Treatment with statins in the acute phase of ischemic stroke. Expert Rev Neurother, 2005, 5(2): 211-221

[7] NamiranianK., KoehlerR. C., SapirsteinA., et al.. Stroke outcomes in mice lacking the genes for neuronal heme oxygenase-2 and nitric oxide synthase. Cur Neurovasc Res, 2005, 2(1): 23-27

[8] LekerR. R., TeichnerA., OvadiaH., et al.. Expression of endothelial nitric oxide synthase in the ischemic penumbra: relationship to expression of neuronal nitric oxide synthase and vascular endothelial growth factor. Brain Res, 2001, 909(1–2): 1-7

[9] ThornberryN. A., LazebnikY.. Caspases: enemies within. Science, 1998, 281(5381): 1312-1316

[10] XingH. Y., SunS. G.. Caspase activated and neuron apoptosis. Foreign Med Sci Section Neurol Neurosurg, 2002, 29(2): 137-140